FibroGen Inc (FGEN)

0.5458 +0.02 (+3.12%) USD  |  NASDAQ  |  Jan 03, 16:00
0.5458 0.00 (0.00%) After-Hours: 04:20
More

FibroGen Research and Development Expense (Annual): 282.86M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for FGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 746.77M
Arbutus Biopharma Corp 73.70M
GlycoMimetics Inc 20.07M
Cidara Therapeutics Inc 68.53M
Cue Biopharma Inc 40.80M